The Interplay of Dietary Fibers and Intestinal Microbiota Affects Type 2 Diabetes by Generating Short-Chain Fatty Acids
- PMID: 36900540
- PMCID: PMC10001013
- DOI: 10.3390/foods12051023
The Interplay of Dietary Fibers and Intestinal Microbiota Affects Type 2 Diabetes by Generating Short-Chain Fatty Acids
Abstract
Foods contain dietary fibers which can be classified into soluble and insoluble forms. The nutritional composition of fast foods is considered unhealthy because it negatively affects the production of short-chain fatty acids (SCFAs). Dietary fiber is resistant to digestive enzymes in the gut, which modulates the anaerobic intestinal microbiota (AIM) and fabricates SCFAs. Acetate, butyrate, and propionate are dominant in the gut and are generated via Wood-Ljungdahl and acrylate pathways. In pancreatic dysfunction, the release of insulin/glucagon is impaired, leading to hyperglycemia. SCFAs enhance insulin sensitivity or secretion, beta-cell function, leptin release, mitochondrial function, and intestinal gluconeogenesis in human organs, which positively affects type 2 diabetes (T2D). Research models have shown that SCFAs either enhance the release of peptide YY (PYY) and glucagon-like peptide-1 (GLP-1) from L-cells (entero-endocrine), or promotes the release of leptin hormone in adipose tissues through G-protein receptors GPR-41 and GPR-43. Dietary fiber is a component that influences the production of SCFAs by AIM, which may have beneficial effects on T2D. This review focuses on the effectiveness of dietary fiber in producing SCFAs in the colon by the AIM as well as the health-promoting effects on T2D.
Keywords: dietary fibers; fermentation; intestinal microbiota; short-chain fatty acids; type 2 diabetes.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10001013/bin/foods-12-01023-g001.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10001013/bin/foods-12-01023-g002.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10001013/bin/foods-12-01023-g003.gif)
Similar articles
-
The impact of short-chain fatty acids on GLP-1 and PYY secretion from the isolated perfused rat colon.Am J Physiol Gastrointest Liver Physiol. 2018 Jul 1;315(1):G53-G65. doi: 10.1152/ajpgi.00346.2017. Epub 2018 Mar 1. Am J Physiol Gastrointest Liver Physiol. 2018. PMID: 29494208
-
Short Chain Fatty Acids, pancreatic dysfunction and type 2 diabetes.Pancreatology. 2019 Mar;19(2):280-284. doi: 10.1016/j.pan.2019.01.021. Epub 2019 Jan 28. Pancreatology. 2019. PMID: 30713129 Review.
-
Short-chain fatty acids and regulation of pancreatic endocrine secretion in mice.Islets. 2019;11(5):103-111. doi: 10.1080/19382014.2019.1587976. Epub 2019 Aug 30. Islets. 2019. PMID: 31469342 Free PMC article.
-
Gut microbial short-chain fatty acids-mediated olfactory receptor 78 stimulation promotes anorexigenic gut hormone peptide YY secretion in mice.Biochem Biophys Res Commun. 2021 Jun 11;557:48-54. doi: 10.1016/j.bbrc.2021.03.167. Epub 2021 Apr 13. Biochem Biophys Res Commun. 2021. PMID: 33862459
-
Short-chain fatty acid receptor and its contribution to glucagon-like peptide-1 release.Digestion. 2014;89(1):31-6. doi: 10.1159/000356211. Epub 2014 Jan 20. Digestion. 2014. PMID: 24458110 Review.
Cited by
-
Gut microbiota microbial metabolites in diabetic nephropathy patients: far to go.Front Cell Infect Microbiol. 2024 May 8;14:1359432. doi: 10.3389/fcimb.2024.1359432. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38779567 Free PMC article. Review.
-
Expression and clinical significance of short-chain fatty acids in patients with intrahepatic cholestasis of pregnancy.World J Hepatol. 2024 Apr 27;16(4):601-611. doi: 10.4254/wjh.v16.i4.601. World J Hepatol. 2024. PMID: 38689740 Free PMC article.
-
Research progress on intestinal microbiota regulating cognitive function through the gut-brain axis.Neurol Sci. 2024 Aug;45(8):3711-3721. doi: 10.1007/s10072-024-07525-5. Epub 2024 Apr 17. Neurol Sci. 2024. PMID: 38632176 Review.
-
Gut Microbiota Targeted Approach by Natural Products in Diabetes Management: An Overview.Curr Nutr Rep. 2024 Jun;13(2):166-185. doi: 10.1007/s13668-024-00523-1. Epub 2024 Mar 18. Curr Nutr Rep. 2024. PMID: 38498287 Review.
-
A two-sample bidirectional Mendelian randomization analysis investigates associations between gut microbiota and type 2 diabetes mellitus.Front Endocrinol (Lausanne). 2024 Mar 1;15:1313651. doi: 10.3389/fendo.2024.1313651. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38495787 Free PMC article.
References
-
- Kreznar J.H., Keller M.P., Traeger L.L., Rabaglia M.E., Schueler K.L., Stapleton D.S., Zhao W., Vivas E.I., Yandell B.S., Broman A.T. Host genotype and gut microbiome modulate insulin secretion and diet-induced metabolic phenotypes. Cell Rep. 2017;18:1739–1750. doi: 10.1016/j.celrep.2017.01.062. - DOI - PMC - PubMed
Publication types
Grants and funding
- Qian Cai Nong [2018]81/Establishment of Guizhou Modern Agriculture Industry Technical System (Characteristic Coarse Cereals)
- (Grant No. [2017] 106)/Key Agricultural Technology Extension Project of Guizhou Province
- Qian Ke He Ping Tai Ren Cai [2018] 5254, [2018] 5781, Qian Ke Zhong Yin Di [2022] 4033, Qian Ke He Zhicheng [2022] Zhongdian 007, Qian Ke He Zhicheng [2021] yiban175, Qian Ke He Jichu [2019]1071, Qian Ke He Zhicheng [2020] 1Y171)/Guizhou Science and Technology Program
LinkOut - more resources
Full Text Sources